Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
Subacute CNS demyelination after treatment with nivolumab for melanoma.
Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Functional brain imaging: an evidence-based analysis.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
A simple, xeno-free method for oligodendrocyte generation from human neural stem cells derived from umbilical cord: engagement of gelatinases in cell commitment and differentiation.
Emerging role of interleukin-22 in autoimmune diseases.
Differential microRNA expression in blood in multiple sclerosis.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Pages
« first
‹ previous
…
352
353
354
355
356
357
358
359
360
…
next ›
last »